What is the appropriate evaluation and management for a patient who develops bleeding after colonoscopy?

Management of Post-Colonoscopy Bleeding

For post-polypectomy bleeding, urgent colonoscopy should be the first-line investigation and treatment, using dual-modality endoscopic therapy (epinephrine injection plus a second modality such as clipping, thermal therapy, or band ligation) to achieve hemostasis 1.

Initial Assessment and Stabilization

When a patient presents with bleeding after colonoscopy, immediately assess hemodynamic status:

• Hypotension or ongoing hemodynamic instability: Requires urgent intervention
• Stable vital signs: Allows for more measured approach
• Resuscitate with crystalloids (normal saline or balanced crystalloids) as needed 2
• Check hemoglobin and coagulation parameters
• Review anticoagulation/antiplatelet status

Timing and Presentation

Post-polypectomy bleeding typically occurs in two patterns:

• Immediate bleeding: Recognized during the procedure (occurs in 9-34% depending on antithrombotic use) 3
• Delayed bleeding: Presents 1-14 days post-procedure, with most cases within the first week 4

The overall incidence of clinically significant post-polypectomy bleeding is approximately 0.6-1.4% 4, 5.

Primary Management Strategy

Endoscopic Therapy (First-Line)

Since the bleeding source is already known from the recent colonoscopy, proceed directly to repeat colonoscopy rather than CT angiography 1. This differs from management of lower GI bleeding from unknown sources.

Bowel preparation considerations:

• If bleeding point is known to be distal (e.g., specific polypectomy site), an enema with copious washing may suffice 1
• For proximal or uncertain locations, rapid purge with 4-6 liters polyethylene glycol over 3-4 hours (may use nasogastric tube) 1
• Blood acts as a natural laxative, often aiding visualization

Endoscopic hemostasis options (all reported as effective in case series) 1:

• Epinephrine injection (typically 1:10,000 dilution)
• Mechanical therapy: Through-the-scope clips, over-the-scope clips, endoscopic band ligation, endoloops
• Thermal therapy: Bipolar coagulation, argon plasma coagulation
• Hemostatic powders

Critical technique points:

• Use CO2 insufflation to reduce explosion risk in poorly prepared colons 1
• Apply dual-modality therapy (epinephrine plus one other method), extrapolating from peptic ulcer bleeding literature 1
• Exercise caution with diathermy/argon plasma coagulation in inadequately prepared bowels

Success Rate of Conservative Management

Most post-colonoscopy bleeding can be managed without surgery 4. In one series, all six patients (100%) with post-polypectomy bleeding were successfully managed with repeat colonoscopy and epinephrine injection, with no rebleeding 4.

When Endoscopy Fails or Is Not Feasible

For Persistently Unstable Patients

If the patient cannot be stabilized for colonoscopy or has ongoing massive bleeding:

1. CT angiography for bleeding localization 6, 2
2. Formal angiography with embolization if CT shows extravasation 6
3. Surgery only as last resort for uncontrolled severe bleeding 2, 7

Avoid technetium-99m red blood cell scintigraphy - it should not be routinely used as it rarely changes management 2.

Surgical Intervention

Reserve surgery for 2, 7:

• Uncontrolled severe bleeding despite endoscopic attempts
• Multiple ineffective nonsurgical treatment attempts
• Hemodynamic collapse refractory to resuscitation

Carefully localize the bleeding source before resection to avoid blind segmental colectomy.

Special Consideration: Anticoagulation/Antiplatelet Therapy

Risk Stratification

Patients on antithrombotic therapy have significantly higher bleeding rates 3, 8:

• Delayed bleeding with antithrombotics: 1.37% vs 0.26% without (p=0.0016) 3
• Immediate bleeding with antithrombotics: 33.86% vs 9.44% without (p<0.001) 3
• Elderly patients on clopidogrel or aspirin face even higher risk 8

Management During Active Bleeding

Do not bridge anticoagulation with heparin - bridging increases bleeding risk (2.7% vs 0.5%, p=0.01) without reducing thromboembolism 9. The exception is patients with mechanical heart valves at very high thrombotic risk, who should be discussed with cardiology.

For patients on aspirin for secondary cardiovascular prevention: Do not stop aspirin even during active bleeding 7. The cardiovascular risk outweighs bleeding risk in established high-risk cardiovascular disease.

Timing of anticoagulation resumption: Base this on severity of bleeding, adequacy of hemostasis achieved, and thromboembolic risk 7. For high-risk patients (e.g., recent venous thromboembolism within 3 months), consider continuing anticoagulation if possible or resuming as soon as hemostasis is secure.

Common Pitfalls to Avoid

1. Don't perform upper endoscopy routinely - only if hematochezia with hemodynamic instability suggests upper GI source 7
2. Don't rush to surgery - 0.1-0.6% perforation rate exists, but most bleeding resolves with endoscopic management 4
3. Don't use single-modality therapy - dual therapy is more effective based on upper GI bleeding data 1
4. Don't order nuclear medicine scans - they delay definitive therapy without improving outcomes 2

Monitoring and Follow-Up

• Most patients who stop bleeding do not rebleed 5
• If rebleeding occurs, repeat colonoscopy with hemostasis 7
• Counsel patients to avoid NSAIDs after recovery, particularly if bleeding was from diverticulosis or angiodysplasia 7